These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 6059285)

  • 1. Change in receptor site affinity: a proposed explanation for the potentiating effect of D-thyroxine on the anticoagulant response to warfarin.
    Solomon HM; Schrogie JJ
    Clin Pharmacol Ther; 1967; 8(6):797-9. PubMed ID: 6059285
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetic analysis of potentiating effect of phenylbutazone on anticoagulant action of warfarin in man.
    O'Reilly RA; Levy G
    J Pharm Sci; 1970 Sep; 59(9):1258-61. PubMed ID: 5469787
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of dextrothyroxine on the kinetics of prothrombin activity: proposed mechanism of the potentiation of warfarin by D-thyroxine.
    Weintraub M; Breckenridge RT; Griner PF
    J Lab Clin Med; 1973 Feb; 81(2):273-9. PubMed ID: 4683426
    [No Abstract]   [Full Text] [Related]  

  • 4. New adjuvants to enhance anticoagulant activity of warfarin.
    Stromich JJ; Weber AK; Mirzaei YR; Caldwell MD; Lewis DE
    Bioorg Med Chem Lett; 2010 Mar; 20(6):1928-32. PubMed ID: 20167480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of oral anticoagulant effect by L-thyroxine.
    Costigan DC; Freedman MH; Ehrlich RM
    Clin Pediatr (Phila); 1984 Mar; 23(3):172-4. PubMed ID: 6697623
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of naproxen on the kinetics of elimination and anticoagulant activity of a single dose or warfarin.
    Slattery JT; Levy G; Jain A; McMahon FG
    Clin Pharmacol Ther; 1979 Jan; 25(1):51-60. PubMed ID: 758243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of the potential drug interaction between warfarin and levothyroxine.
    Wood MD; Delate T; Clark M; Clark N; Horn JR; Witt DM
    J Thromb Haemost; 2014 Aug; 12(8):1313-9. PubMed ID: 24913218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of effect of warfarin on L-thyroxine metabolism.
    Wright DL; Carlson HE; Hershman JM; Adelstein EH
    Horm Metab Res; 1987 Jul; 19(7):323-4. PubMed ID: 3623421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of anticoagulant effect of warfarin by phenylbutazone.
    Aggeler PM; O'Reilly RA; Leong L; Kowitz PE
    N Engl J Med; 1967 Mar; 276(9):496-501. PubMed ID: 6018280
    [No Abstract]   [Full Text] [Related]  

  • 10. Alterations in the effects of warfarin in dogs by halofenate: an influence upon the kinetics of prothrombin.
    Weintraub M; Griner PF
    Thromb Diath Haemorrh; 1975 Nov; 34(2):445-54. PubMed ID: 1198407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Danazol increases the anticoagulant effect of warfarin.
    Meeks ML; Mahaffey KW; Katz MD
    Ann Pharmacother; 1992 May; 26(5):641-2. PubMed ID: 1591422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative interaction of cimetidine and ranitidine with racemic warfarin in man.
    O'Reilly RA
    Arch Intern Med; 1984 May; 144(5):989-91. PubMed ID: 6324710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant effect of capecitabine on the pharmacokinetics and pharmacodynamics of warfarin in patients with cancer.
    Camidge R; Reigner B; Cassidy J; Grange S; Abt M; Weidekamm E; Jodrell D
    J Clin Oncol; 2005 Jul; 23(21):4719-25. PubMed ID: 16034047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral anticoagulant drugs: pharmacokinetic aspects.
    Breckenridge A
    Semin Hematol; 1978 Jan; 15(1):19-26. PubMed ID: 341326
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of Shuxuetong injection on anticoagulant effect of warfarin in rats].
    Zhao HF; Sun JH; Liu S; Liu Y; Liu GF
    Zhongguo Zhong Yao Za Zhi; 2017 Mar; 42(5):982-988. PubMed ID: 28994544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Miconazole oral gel potentiates warfarin anticoagulant activity.
    Silingardi M; Ghirarduzzi A; Tincani E; Iorio A; Iori I
    Thromb Haemost; 2000 May; 83(5):794-5. PubMed ID: 10823285
    [No Abstract]   [Full Text] [Related]  

  • 17. Trans-Resveratrol Enhances the Anticoagulant Activity of Warfarin in a Mouse Model.
    Chiba T; Kimura Y; Suzuki S; Tatefuji T; Umegaki K
    J Atheroscler Thromb; 2016 Sep; 23(9):1099-110. PubMed ID: 26947597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fenofibrate potentiates warfarin effects.
    Kim KY; Mancano MA
    Ann Pharmacother; 2003 Feb; 37(2):212-5. PubMed ID: 12549950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Stereoselectivity of the warfarin effect].
    Mohr K
    Dtsch Med Wochenschr; 1984 Dec; 109(50):1943-4. PubMed ID: 6510246
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diphenylhydantoin interaction with warfarin].
    Honda Y; Katayama T
    Nihon Naika Gakkai Zasshi; 1982 Aug; 71(8):1114-9. PubMed ID: 7175314
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.